Hydroxyproline metabolism was studied in two patients with type II hyperprolinaemia (HP II) using oral loadings of hydroxyproline or hydroxyproline-ornithine. ['.,--pyrroline-j-hydroxy-5-carboxylic acid (3 OH-PC) and ['., were identified in the urine. The urinary excretion of both 3-0H-PC and PC increased in HP II patients but not in healthy controls during oral loading of hydroxyproline and hydroxyproline-ornithine.
SUMMARY Hydroxyproline metabolism was studied in two patients with type II hyperprolinaemia (HP II) using oral loadings of hydroxyproline or hydroxyproline-ornithine. ['.,--pyrroline-j-hydroxy-5-carboxylic acid (3 OH-PC) and ['., were identified in the urine. The urinary excretion of both 3-0H-PC and PC increased in HP II patients but not in healthy controls during oral loading of hydroxyproline and hydroxyproline-ornithine.
The plasma level of proline in patients with HP II is very high but the hydroxyproline concentration is normal or only slightly increased. Therefore one can assume that hydroxyproline is converted to pyrrole-2-carboxylic acid, which is excreted in urine as a glycine conjugate.
In this study it was demonstrated that the highly elevated plasma level of proline in one of the patients with HP II decreased greatly after hydroxyproline-ornithine load; this change was followed by a 40-fold rise in urinary excretion of proline.
The hyperprolinaemias are rare metabolic disorders caused by inherited biochemical abnormalities in the pathway of proline degradation (Fig. 1 ). Both Fig. 1 Metabolic reactions of free proline. Enzymes corresponding to the numbered reactions are: (I) proline  oxidase; (2) 5PC reductase; (3) 5PC dehydrogenase; (4) this step has not been enzymically characterised and may involve more than one enzyme; (5) ornithineketoacid aminotransferase; (6) 2PC reductase; (7) t.-amino-acid oxidase; (8) spontaneous, not known to be enzymatic. The main reactions are indicated by heavy arrows, and the metabolic blocks in hyperprolinaemias I and II are shown: 5PC
6. l-pyrroline-5-carboxylic acid; 2PC = 6. l-pyrroline-2-carboxylic acid.
DIETARY PROTEINS TISSUE RRO'TEINS type I hyperprolinaemia (HP I) and type II hyperprolinaemia (HP II) are characterised by elevated plasma proline concentrations. The increase in renal filtered load of proline results in iminoglycinuria with increased urinary excretion of proline, hydroxyproline, and glycine. The distinguishing feature of HP II, however, is the very high plasma level of proline and the urinary excretion of large amounts of /':"l-pyrro line compounds. The presence of these compounds results in the appearance of a characteristic orange colour when the urine of HP II patients is reacted with o-aminobenzaldehyde (DAB) (Simila, 1970a) . The underlying biochemical abnormality of HP I has been shown to be a deficiency of proline oxidase, the first enzyme in the proline degradative pathway (Efron, 1965) . Recently, Valle et al. (1976) demonstrated an absence of /':,,1-pyrroline-5-carboxylic acid dehydrogenase activity in the cultured fibroblasts and in the leucocyte extracts from three patients with HP II. Furthermore, Goodman et al. (1974) reported that their HP II patients also had a defect in hydroxyproline metabolism, and the pathways for proline and hydroxyproline catabolism appear to share a common /':,,1-pyrro line-5-carboxylic acid dehydrogenase. We therefore investigated the hydroxyproline metabolism in our two patients with HP II. At the time of this study both boys were healthy and leading a normal life. For oral loading Lhydroxyproline (OH-PRO), 100 rng/kg, was administered after an overnight fast to case 1 and to control A. OH-PRO, 100 mg/kg, and ornithine (ORN), 100 rng/kg, was administered respectively to case 2 and to control B. Plasma samples were obtained at 0, 2, 3, 5, and 8 hours from the start of loading. The duration of urine collections was 24 hours.
METHODS
Urine samples were refrigerated and were pooled and frozen at -4°C at the end of each 24-hour collection period. Plasma samples were frozen at -20°C. Concentrations of amino-acids in plasma and urine were determined using a JEOL-JLC-GAH amino-acid analyser. The plasma samples (I ml) were deproteinised using 3 % sulphosalicylic acid (4 ml). Thereafter centrifugation (20000 g) for 10 minutes was carried out. The supernatant was diluted 1:1 with 0'2-N lithium citrate buffer, pH 2'2. The concentrations of t:, 1_ pyrroline-5-carboxylic acid (PC) and t:, 1-pyr ro line-3-hydro xy-5-carboxylic acid (3 OH-PC) were determined according by abnormal compounds which are shown in Figure  2 . Peak 1 is the larger and is identified as 3 OH-PC. Peak 2 has similar 570/440 nm absorbance properties to synthetic PC. Urinary excretion, renal clearance, and tubular reabsorption of proline, hydroxyproline, glycine, and ornithine are presented in Table 2 . The concentrations of free amino-acids in plasma of the patients were normal except for proline, 2·497 umol/ml (case 1) and 3·551 umol/ml (case 2) (normal = 0'07-0'15 urnoljrnl). In addition minor elevations of the peak concentrations of ornithine (0'132 and 0·133 (normal = 0'02-0'086) umol/rnl) and alanine (0'341 and 0·366 (normal 0·137-0'305)~mol/m1)) were observed. patients were slightly greater than those observed in both controls. The fasting plasma concentration of ornithine ( Fig. 4) was only slightly increased jn the children with HP II. It increased a little further in case 1 after administration of hydroxyproline. The load of hydroxyproline-ornithine produced high elevation of plasma ornithine in case 2 with HP II. The hydroxyproline loading did not influence the plasma proline level in the normal subjects ( Fig. 5 ) but led to a rise of the plasma concentration of this aminoacid in case 1 with HP II. On the other hand, when hydroxyproline was combined with ornithine a thought to be PC, but recent evidence shows that the major fraction of the OAB-reactive material is 3 OH-PC, the oxidised degradative product of hydroxyproline (Applegarth et al., 1974; Goodman et al., 1974) . The presence of a block in the oxidative degradation of hydroxyproline was further supported by our results of hydroxyproline loading. In particular, the high plasma hydroxyproline levels produced and the urinary excretion of such large amounts of hydroxyproline and 3 OH-PC point in this direction. Furthermore, on the basis of copurification of the dehydrogenase activities for PC and 3 OH-PC, Adams and Goldstein (1960) have suggested that a single enzyme catalyses the oxidation of both PC and 3 OH-PC. Valle et al. (1976) have recently demonstrated an absence of PC dehydrogenase acitivity in the cultured fibroblasts and leucocyte extracts from three patients with HP II. Thus HP II and hydroxyprolinaemia II are alternative names of the same disorder.
The enzyme defects causing HP II should lead to an increased plasma level of hydroxyproline but the concentration of this compound is normal in these patients and only slightly elevated in other patients reported (Goodman et al., 1974) . As Heacock and Adams (1973 have demonstrated that pyrrole-Z-carboxylic acid (2PC) can be formed in mammals from L-hydroxyproline (Fig. 6 ), it is probable that OH-PRO is metabolised through this pathway also in HP II patients. The hypothesis is further supported by the findings of Applegarth et al. (1977) , who using highly sensitive and specific mass spectrometric methods identified the glycine conjugate of 2PC. Thus, it is probable that the excess The urinary excretion of 3 OH-PC increased eightfold after hydroxyproline load (case 2). The urinary excretion of PC rose only slightly immediately after hydroxyproline-ornithine load and stopped completely after 3 hours of load. No urinary excretion of 3 OR-PC and PC was observed in controls A and B.
The urinary excretion of proline was unchanged after the load of hydroxyproline (Table 3 ; case 1) but increased greatly after hydroxyproline-ornithine load (case 2). Table 3 Urinary excretion of hydroxyproline (OH-Pro) . proline (Pro), ornithine (Om), 6. 1 -pyrroline-5-carboxy lic acid (PC), and 6. I-pyrroline-3-hydroxy-5-carboxylic acid (3 OH-PC) after oral hydroxyproline (100 mg/kg; case J and control A) or after oral hydroxyproline (lOOmg/kg) and ornithine (lOami/kg; case 2 and control B).
Concentrations quoted as umollumol creatinine

Discussion
The biochemical findings of HP II include highly elevated plasma proline concentrations, iminoglycinuria, and the urinary excretion of OAB-reactive material. This OAB-positive material was initially Fig. 6 Degradation of free hydroxyproline. Enzymes corresponding to the numbered reactions are: (1) hydroxyproline oxidase; (2) HPC dehydrogenase; (3) spontaneous, not known to be enzymatic; (4) L-amino-acid oxidase. The metabolic block in hydroxyprolinaemia is indicated: HPC = 6. 1 -pyrroline-3-hydroxy-5-carbox ylic acid; HGA = 4-hydroxyglutamic acid.
Hydroxyproline metabolism in type Il hyperprolinaemia of OH-PRO in HP II patients is excreted in urine as glycine-conjugated 2PC.
Of special interest is the fact that patients with HP II have much higher plasma proline concentrations than those with HP r. This difference in proline accumulation may be explained by a partial rather than complete deficiency of proline oxidase in HP I, although enzyme assays, in a single patient with HP T, indicated that the defect was virtually complete (Efron, 1965) . A more probable explanation for the higher plasma proline concentrations in HP II involves the contribution from ornithine to the proline pool, as normally a significant amount of ornithine is converted to PC by ornithine-ketoacidaminotransferase and thence to glutamate by PC dehydrogenase (Adams, 1970) . This pathway is not interrrupted in HP T. In HP II, however, with a block in the conversion of PC to glutamate, PC derived from ornithine will accumulate and, in turn, add to the proline pool. We have shown previously a 10 to 20-fold increase in urine OAB-reactive material after ornithine load in patients with HP II (Simila, 1970b) . In this patient the urinary excretion of ornithine increased fourfold after hydroxyproline load and the ornithine plasma level rose slightly. Tn addition, the hydroxyproline-ornithine load in our second patient produced a very high hyperornithinaemia.
In the present study the elevated plasma concentration of proline in the patient with HP II decreased from 3·85 umol/ml to 2·03 umol/ml after hydroxyproline-ornithine load. This change was followed by a 40-fold rise in the urinary excretion of proline. Hotzapple et al. (1973) have shown in human kidney cortex slices that 90 % of proline transported by the tubule cells is rapidly metabolised to glutamate. In HP II the kidney tubule cells are exposed to saturating concentrations of proline and also hydroxyproline, but in HP IT the degradation of these amino-acids is blocked. Therefore the tubule cells must accumulate larger amounts of PC and 3 OH-PC, which either diffuse back into the tubule lumen and appear in the urine, or interfere with the renal transport of proline by a mechanism similar to that shown with glycine loading (Raine, 1975) . Thus one can assume that the high concentration of ornithine in plasma and tubule cells causes the excessive excretion of proline in urine from the kidney cells, causing a decrease of the plasma proline level during hydroxyproline-ornithine loading of the patient with HP IT.
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